Steward Partners Investment Advisory’s Genmab GMAB Stock Holding History

Steward Partners Investment Advisory’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.86K	Buy	104 +24	+30%	+$638	﹤0.01%	4147
2026 Q1	$2.15K	Hold	80	–	–	﹤0.01%	4037
2025 Q4	$2.46K	Hold	80	–	–	﹤0.01%	3904
2025 Q3	$2.45K	Hold	80	–	–	﹤0.01%	3869
2025 Q2	$1.65K	Hold	80	–	–	﹤0.01%	3776
2025 Q1	$1.57K	Hold	80	–	–	﹤0.01%	3690
2024 Q4	$1.67K	Hold	80	–	–	﹤0.01%	3675
2024 Q3	$1.95K	Buy	80 +4	+5%	+$107	﹤0.01%	3439
2024 Q2	$1.91K	Buy	+76	New	+$2.15K	﹤0.01%	3289
2024 Q1	–	Sell	-22	Closed	-$700	–	3605
2023 Q4	$700	Buy	+22	New	+$691	﹤0.01%	3332
2021 Q2	–	Sell	-65	Closed	-$2.13K	–	7213
2021 Q1	$2.13K	Hold	65	–	–	﹤0.01%	3215
2020 Q4	$3K	Hold	65	–	–	﹤0.01%	2627
2020 Q3	$2K	Hold	65	–	–	﹤0.01%	2567
2020 Q2	$2K	Hold	65	–	–	﹤0.01%	2470
2020 Q1	$1K	Hold	65	–	–	﹤0.01%	2377
2019 Q4	$1K	Buy	+65	New	+$1.42K	﹤0.01%	2506

Other funds holding GMAB

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Steward Partners Investment Advisory's GMAB Position: Q2 2026 in Review

Steward Partners Investment Advisory increased its Genmab (GMAB) stake by 30% in Q2 2026, buying an estimated $638 and bringing the position to 104 shares worth $2.86K. The position accounts for ﹤0.01% of the portfolio, ranked #4147.

Steward Partners Investment Advisory first reported a position in GMAB in Q4 2019 and has held it in 16 quarters since. The position peaked at $3K in Q4 2020. 290 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

Steward Partners Investment Advisory held 104 shares of Genmab worth $2.86K as of Q2 2026.
Steward Partners Investment Advisory bought 24 Genmab shares in Q2 2026, an estimated $638.
Genmab made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #4147 holding.
Steward Partners Investment Advisory first reported a position in Genmab in Q4 2019 and has held it in 16 quarters since.
Steward Partners Investment Advisory's Genmab position peaked at $3K in Q4 2020.
290 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.